My Attendance at the 2024 Boston Society Cell and Gene Therapy Conference
Alta Sciences
JUNE 11, 2024
Milton also highlighted which assessments are optional for the development of gene therapies and how eliminating them could save sponsors time and money, while listing those that are essential to consider, including shedding, biodistribution , and cellular immune response assays and neutralizing antibody assays.
Let's personalize your content